Aristoforin: derivative of hyperforin, is a potent anticancer agent; structure in first source
ID Source | ID |
---|---|
PubMed CID | 98185391 |
CHEMBL ID | 3956664 |
MeSH ID | M0487212 |
Synonym |
---|
CHEMBL3956664 , |
aristoforin |
bdbm50193078 |
849215-53-8 |
2-[[(1r,5r,6r,7s)-6-methyl-1,3,7-tris(3-methylbut-2-enyl)-6-(4-methylpent-3-enyl)-5-(2-methylpropanoyl)-4,9-dioxo-2-bicyclo[3.3.1]non-2-enyl]oxy]acetic acid |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | IC50 (µMol) | 21.0000 | 0.5000 | 3.8481 | 10.0000 | AID1317177 |
NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | IC50 (µMol) | 7.0000 | 0.0060 | 1.6250 | 9.0000 | AID1317176 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1320341 | Inhibition of 50 nM N-terminal His6-tagged recombinant human SIRT1 expressed in Escherichia coli at 100 uM using RHKK(Ac)W-NH2 as substrate after 30 mins by UV detection-based HPLC method | 2016 | Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20 | Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity. |
AID1320343 | Activation of 50 nM N-terminal His6-tagged recombinant human SIRT1 expressed in Escherichia coli at 100 uM using RHKK(Ac)W-NH2 as substrate after 30 mins in presence of 0.01% TX-100 by UV detection-based HPLC method relative to control | 2016 | Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20 | Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity. |
AID1320340 | Inhibition of 250 nM N-terminal His6-tagged recombinant human SIRT1 expressed in Escherichia coli at 100 uM using RHKK(Ac)W-NH2 as substrate after 5 to 10 mins by UV detection-based HPLC method | 2016 | Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20 | Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity. |
AID1317177 | Inhibition of recombinant human GST-tagged SIRT2 overexpressed in Escherichia coli DH5alpha assessed as deacetylation activity using [3H]-MPSDKTIGG as substrate measured after overnight incubation by liquid scintillation counting method | 2016 | European journal of medicinal chemistry, Aug-25, Volume: 119 | How much successful are the medicinal chemists in modulation of SIRT1: A critical review. |
AID1320339 | Inhibition of N-terminal His6-tagged recombinant human SIRT1 expressed in Escherichia coli at 32 uM using RHKK(Ac)W-NH2 as substrate by UV detection-based HPLC method | 2016 | Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20 | Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity. |
AID1320344 | Activation of 25 nM N-terminal His6-tagged recombinant human SIRT1 expressed in Escherichia coli at 100 uM using RHKK(Ac)W-NH2 as substrate after 1 hr in presence of 0.01% TX-100 by UV detection-based HPLC method relative to control | 2016 | Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20 | Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity. |
AID1317176 | Inhibition of recombinant human GST-tagged SIRT1 overexpressed in Escherichia coli DH5alpha assessed as deacetylation activity using [3H]-MPSDKTIGG as substrate measured after overnight incubation by liquid scintillation counting method | 2016 | European journal of medicinal chemistry, Aug-25, Volume: 119 | How much successful are the medicinal chemists in modulation of SIRT1: A critical review. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |